NCT06390696

Sand Play - the Effect of Biodiversity Exposure on Atopic Dermatitis

Name: Clinical Trial NCT06390696
Creator: Natural Resources Institute Finland
Keywords: Atopic Dermatitis,Nature, Human,Microbial Colonization,Immune System and Related Disorders, Microbial intervention, biological, clinical trial, Finland

Biodiversity Interventions for Well-being - the Effect of Biodiversity Exposure on Atopic Dermatitis

Natural Resources Institute Finland·ClinicalTrials.gov·biologicalRecruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Atopic Dermatitis,Nature, Human,Microbial Colonization,Immune System and Related Disorders
Drug/Device/Intervention: Microbial intervention
Study type: Interventional
Intervention type: biological

Sponsor & location

Primary sponsor: Natural Resources Institute Finland
Location: Helsinki,Tampere, Finland

Timeline & enrollment

Phase: N/A
Start date: May 26, 2023
End date: Sep 30, 2027
Enrollment: 80 participants

Primary outcome

Eczema Area and Severity Index (EASI)

Summary

The prevalence of atopic dermatitis has increased along with urbanization and biodiversity loss. According to biodiversity hypothesis, the main reason is urban lifestyle and reduced contact to microbial diversity. Previous studies indicate association between atopic dermatitis and exposure to natural microbes in childhood.  Sand Play - the Effect of Biodiversity Exposure on Atopic Dermatitis will investigate whether the exposure to microbial diversity in sandbox reduces the symptoms of atopic dermatitis, alters commensal microbiota and modifies immune regulation in children.

ICD-10 classifications

Atopic dermatitisOther atopic dermatitisAtopic dermatitis, unspecifiedOther dermatitisAllergic contact dermatitis

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06390696
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06390696 through Pure Global AI's free database. This phase not specified trial is sponsored by Natural Resources Institute Finland and is currently Recruiting. The study focuses on Atopic Dermatitis,Nature, Human,Microbial Colonization,Immune System and Related Disorders. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.